Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain Barré Syndrome
- 23 March 2020
- journal article
- research article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 75, 176-180
- https://doi.org/10.1016/j.jocn.2020.03.010
Abstract
No abstract availableKeywords
Funding Information
- SERB (SB/SO/HS-209/2013)
This publication has 31 references indexed in Scilit:
- Elevated Levels of Cerebrospinal Fluid and Plasma Interleukin-37 in Patients with Guillain-Barré SyndromeMediators of Inflammation, 2013
- IL-17 and IL-22 in Cerebrospinal Fluid and Plasma Are Elevated in Guillain-Barré SyndromeMediators of Inflammation, 2012
- An appraisal of blood-cerebrospinal fluid barrier dysfunction during the course of Guillain Barré syndromeNeurology India, 2009
- IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+regulatory T cellsProceedings of the National Academy of Sciences, 2008
- T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγImmunity, 2008
- The Guillain–Barré syndrome: a true case of molecular mimicryTrends in Immunology, 2004
- Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndromeBrain, 2003
- Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathiesJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcomeAnnals of Neurology, 1998
- Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathyJournal of Neuroimmunology, 1993